Cas:53967-38-7 1-Hydroxy-1H-imidazole-2-carboxamide 3-oxide manufacturer & supplier

Chemical Name:1-Hydroxy-1H-imidazole-2-carboxamide 3-oxide

CAS.NO:53967-38-7

Synonyms:1-hydroxy-3-oxy-1H-imidazole-2-carbaldehyde oxime;1-Hydroxy-imidazol-2-carboxaldoxim-3-oxid;2-carbamoyl-1-hydroxyimidazole 3-oxide;1-hydroxy-2-hydroxyiminomethylimidazole-3-oxide;2-Carboxamido-1-hydroxyimidazol-3-oxid;1-Hydroxy-3-oxy-1H-imidazol-2-carbaldehyd-oxim;1-hydroxy-3-oxy-1H-imidazole-2-carboxylic acid amide;1-Hydroxyimidazol-2-aldehydoxim-3-oxid

Molecular Formula:C₄H₅N₃O₃

Molecular Weight:143.10100

HS Code:2933290090

Physical and Chemical Properties:

Melting point:N/A

Boiling point:N/A

Density:N/A

Index of Refraction:

PSA:93.71000

Exact Mass:143.03300

LogP:

Material Safety Information (Applicable for Hazard Chemicals)

RIDADR:

Packing Group:

Contact us for information like 1-hydroxy-3-oxy-1H-imidazole-2-carbaldehyde oxime chemical properties,Structure,melting point,boiling point,density,molecular formula,molecular weight,1-Hydroxyimidazol-2-aldehydoxim-3-oxid physical properties,toxicity information,customs codes,safety, risk, hazard and MSDS, CAS,cas number,2-carbamoyl-1-hydroxyimidazole 3-oxide Use and application,1-hydroxy-2-hydroxyiminomethylimidazole-3-oxide technical grade,usp/ep/jp grade.

Related News: US citizens who have been to China in the last 14 days need to re-book to one of seven gateway airports: John F. Kennedy International Airport in New York, Los Angeles International Airport, Seattle, San Francisco International Airport, Chicago, Atlanta and Honolulu. 1-Hydroxy-1H-imidazole-2-carboxamide 3-oxide manufacturer Madeleine Roche, Associate Pharmaceutical Analyst at GlobalData, comments: ��Within the top 20 global companies that spent the most on R&D in 2018, the top spender �C despite having the second smallest annual revenue of the group at $15.28 billion �C is Celgene, whose R&D spend was equal to 37% of its annual revenue. 1-Hydroxy-1H-imidazole-2-carboxamide 3-oxide supplier At the same time, due to the increase in production costs and environmental protection cost pressures in Europe and the United States, as well as the improvement of process technology, production quality, and registration and certification capabilities of China’s bulk drug manufacturers, bulk drug companies have accelerated their transfer to China, and the bulk drug industry in China has produced Scale continues to increase. 1-Hydroxy-1H-imidazole-2-carboxamide 3-oxide vendor At the same time, due to the increase in production costs and environmental protection cost pressures in Europe and the United States, as well as the improvement of process technology, production quality, and registration and certification capabilities of China’s bulk drug manufacturers, bulk drug companies have accelerated their transfer to China, and the bulk drug industry in China has produced Scale continues to increase. 1-Hydroxy-1H-imidazole-2-carboxamide 3-oxide factory ICIG companies currently employ more than 3,000 people and operate 15 manufacturing facilities in Europe and the United States.